A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy

Clinical Trial Site, Los Angeles, California, United States

Clinical Trial Site, Orange, California, United States

Clinical Trial Site, Palo Alto, California, United States

Clinical Trial Site, Sacramento, California, United States

Clinical Trial Site, San Francisco, California, United States

Clinical Trial Site, Aurora, Colorado, United States

Clinical Trial Site, New Haven, Connecticut, United States

Clinical Trial Site, Gainesville, Florida, United States

Clinical Trial Site, Jacksonville, Florida, United States

Clinical Trial Site, Maitland, Florida, United States

Clinical Trial Site, Naples, Florida, United States

Clinical Trial Site, Chicago, Illinois, United States

Clinical Trial Site, Lexington, Kentucky, United States

Clinical Trial Site, New Orleans, Louisiana, United States

Clinical Trial Site, Boston, Massachusetts, United States

Clinical Trial Site, Plymouth, Massachusetts, United States

Clinical Trial Site, Rochester, Minnesota, United States

Clinical Trial Site, St Louis, Missouri, United States

Clinical Trial Site, Hackensack, New Jersey, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, Durham, North Carolina, United States

Clinical Trial Site, Canton, Ohio, United States

Clinical Trial Site, Cleveland, Ohio, United States

Clinical Trial Site, Abington, Pennsylvania, United States

Clinical Trial Site, Philadelphia, Pennsylvania, United States

Clinical Trial Site, Pittsburgh, Pennsylvania, United States

Clinical Trial Site, Dallas, Texas, United States

Clinical Trial Site, Dallas, Texas, United States

Clinical Trial Site, Houston, Texas, United States

Clinical Trial Site, San Antonio, Texas, United States

Clinical Trial Site, Seattle, Washington, United States

Clinical Trial Site, Adelaide, Australia

Clinical Trial Site, Brisbane, Australia

Clinical Trial Site, Heidelberg, Australia

Clinical Trial Site, Nedlands, Australia

Clinical Trial Site, Parkville, Australia

Clinical Trial Site, Calgary, Canada

Clinical Trial Site, Hamilton, Canada

Clinical Trial Site, Kelowna, Canada

Clinical Trial Site, Moncton, Canada

Clinical Trial Site, Montreal, Canada

Clinical Trial Site, Montreal, Canada

Clinical Trial Site, Ottawa, Canada

Clinical Trial Site, Toronto, Canada

Clinical Trial Site, Victoria, Canada

Clinical Trial Site, Amsterdam, Netherlands

Clinical Trial Site, Leiden, Netherlands

Clinical Trial Site, Nijmegen, Netherlands

Clinical Trial Site, Bern, Switzerland

Clinical Trial Site, Geneva, Switzerland

Clinical Trial Site, Sankt Gallen, Switzerland

Clinical Trial Site, Glasgow, United Kingdom

Clinical Trial Site, London, United Kingdom

Clinical Trial Site, London, United Kingdom